Choosing the best research
The Muscular Dystrophy Campaign works relentlessly to identify and invest in the most promising research, funding world-class pioneering research into potential treatments and cures for people with muscular dystrophy and related neuromuscular conditions, from basic science and translational research to clinical pilot studies.
It is due to this rigorous selection process that the charity sucessfully funds research projects at an early stage; which leads to promising research developments, clinical trials, and large investments from funding bodies. We laid the foundations of exon-skipping technology – a potential therapy for Duchenne muscular dystrophy – which is now in clinical trial, and funded work that led to a scientific breakthrough with the potential to stop mitochondrial myopathy being passed from mother to child.
The Muscular Dystrophy Campaign funding for our research is absolutely crucial, it’s been crucial for a number of years. One of the really important aspects about the Muscular Dystrophy Campaign research is that they are prepared to fund research at a very early stage of development. So they're prepared to fund ideas that might ultimately help patients with neuromuscular disease and I think this is a very innovative approach.”
Professor Doug Turnbull, researcher at the University of Newcastle